The Weston Brain Institute has new funding opportunities available. Please have a close look:

All funding programs support translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging. As the Institute defines it, these diseases include:

· Alzheimer’s disease

· Amyotrophic lateral sclerosis (ALS)

· Dementia with Lewy bodies

· Frontotemporal dementia

· Mild cognitive impairment as prodromal to one of the other listed diseases

· Multiple system atrophy

· Parkinson’s disease

· Progressive supranuclear palsy

Submissions open: approximately August 2014

Seed funding (up to $150,000 for up to 18 months) for high-risk, high-reward, totally novel ideas.

One Time Program:

2014 Targeted Diseases: FTD and PSP*

Application deadline: Friday, June 6th, 2014

The Institute will commit up to $1.35 million to this program. Per project, funding can range from $50,000 to $150,000 per year over 1 to 3 years to a maximum of $450,000.

The Institute will commit up to $1.35 million to this program. Funding can range from $50,000 to $150,000 per year over 1 to 3 years to a maximum of $450,000.

research in frontotemporal dementia (FTD) and/or progressive supranuclear palsy (PSP).

Research in other overlapping tauopathies, such as corticobasal degeneration, is not supported at this time.

/sent on behalf of

Chris M. Anderson, PhD

President – Winnipeg Chapter Society for Neuroscience

Associate Professor and Director, Neuroscience Research Program

Kleysen Institute for Advanced Medicine

Health Sciences Centre and University of Manitoba

T:  204-318-2565

E:  chris.anderson@med.umanitoba.ca

Kelly Jorundson
Executive Assistant
Winnipeg Chapter Society for Neuroscience
R4046 - 351 Tache Avenue
Winnipeg, MB  R2H 2A6

Tel: 204.235.3939  Fax: 204.237.4092
Email:  kjorund@sbrc.ca OR Kelly.jorundson@med.umanitoba.ca

Website:  www.sfn-manitoba.ca